Efficacy study of daily fractionated oral iron in adults with iron deficiency anemia——a single center, randomized controlled study

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200062595

Enrollment

Unknown

Registered

2022-08-13

Start date

2022-09-01

Completion date

Unknown

Last updated

2023-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

iron deficiency anemia

Interventions

Group A:100mg Ferrous succinate,once a day

Group B:100mg Ferrous succinate,twice a day

Group C:100mg Ferrous succinate,three times a day

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Outpatients who seek medical advise in Huashan hospital affiliated of Fudan university in 2022-2023; 2. Meets diagnostic criteria for IDA (1) Microcytic hypochromic anemia: hemoglobin (HB) 64.44 µ mol/LAge >= 18 years (3)Willing to sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Pregnant women; 2. Had severe gastric ulcers that did not tolerate oral therapy; 3. Had severe uncontrollable active bleeding; 4. Severe/life-threatening anemia; Other anemias that can cause IDA, such as PNH and others; 5. Inflammatory bowel disease; 6. After gastrointestinal/bariatric surgery; 7. Perioperative; 8. Chronic kidney disease; 9. Cancer; 10. Serious infection.

Design outcomes

Primary

Measure	Time frame
hemoglobin;	—

Secondary

Measure	Time frame
Reticulocyte;ferritin;Serum iron;Total iron binding capacity;Transferrin saturation;	—

Countries

China

Contacts

Public ContactWei Wang

ciwei108@sina.com+86 13621762178

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026